Danda Trouve Investment Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Danda Trouve Investment Management, Inc.

  • $54.1 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021
SELL
$478.3 - $607.98 $2,391 - $3,039
-5 Closed
0 $0
Q3 2020

Oct 28, 2020
SELL
$544.75 - $658.21 $13,618 - $16,455
-25 Reduced 83.33%
5 $3,000
Q2 2020

Aug 03, 2020
SELL
$493.32 - $643.92 $4,933 - $6,439
-10 Reduced 25.0%
30 $19,000
Q1 2020

Apr 22, 2020
BUY
$336.18 - $494.43 $13,447 - $19,777
40 New
40 $20,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Danda Trouve Investment Management, Inc. Portfolio

Follow Danda Trouve Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danda Trouve Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Danda Trouve Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email